about
Role of cytochrome P450 in drug interactionsFrequency and clinical relevance of potential cytochrome P450 drug interactions in a psychiatric patient population - an analysis based on German insurance claims data.Drug interactions with angiotensin receptor blockers.The physiological and pharmacological roles of cytochrome P450 isoenzymes.Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole.P-glycoprotein and drug therapy in organ transplantation.Drug interactions of the newer oral antifungal agents.Pharmacogenetics and psychopharmacotherapy.The metabolic profile of second-generation antihistamines.Observation and experiment on the cusp of collaboration: a parallel examination of clinical pharmacology and pharmacoepidemiology.Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycinTreatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions.Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin.Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know.Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction.Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activityGenetic polymorphisms analysis of CYP2D6 in the Uygur population.A microphysiological system model of therapy for liver micrometastasesThe role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy.Selective Inhibition of Bakuchicin Isolated from Psoralea corylifolia on CYP1A in Human Liver MicrosomesPolymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.Using computer databases to predict and avoid drug-drug interactions in the cancer patient requiring psychotropics.Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey.Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.Torsade de pointes induced by cisapride/clarithromycin interaction.Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction.Fatal cardiac event following initiation of risperidone therapy.Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers.Evaluation of dextromethorphan N-demethylation activity as a biomarker for cytochrome P450 3A activity in man.HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions.Enhanced hypoprothrombinemia with warfarin due to azithromycin.Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine.The Residual Medium and Long-term Cognitive Effects of Benzodiazepine Use: An Updated Meta-analysis.Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice.AmineDB: large scale docking of amines with CYP2D6 and scoring for druglike properties--towards defining the scope of the chemical defense against foreign amines in humans.Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats.Improving family ties: an examination of the complementary disciplines of pharmacoepidemiology and clinical pharmacology.
P2860
Q21245066-30F4D231-52A9-48C1-9235-BE27A9941AA3Q31127895-3A437A5D-B8D7-4DA6-B307-CC49E631FCB5Q33211891-019D8BB7-E786-40B5-91E0-C1CE61407297Q33597477-57764525-3873-404B-9748-6E12223D77C1Q33734852-B92D2140-0C41-4F67-8CC2-39A30248CE52Q33749785-17815E67-C211-498E-8A52-3B7DD0F65B51Q33871614-F4964553-43E4-4336-9A90-1287549CD665Q33962212-B07DA068-02E2-44AE-9FE6-9728A45D94E4Q33963369-8457145A-5A4C-4D88-AE61-B71079BDCB3CQ34024124-B5A6BFB2-3292-4935-8C4B-2278D9CFC7E4Q34049823-AE800AB1-8F16-4F77-880A-0989E1A3DB51Q34389584-C74D1CF0-E96D-479E-A372-63CC8BB0AA99Q34773911-347A45CA-0FBE-4A64-AB0F-3DE86FF3165DQ35000765-EA84C91B-360B-4AAC-9089-5CB8CCADD815Q35060812-EB3233F5-4B5F-4197-A783-392B8DAF6C11Q35195182-2A11A1D9-5052-4EE5-9BA7-159A27F74543Q35608207-E00046BB-E205-45BA-A8B9-D86C4B5E8583Q35827367-BF84719F-6351-4307-AFAF-562B4BDC0A0DQ35827674-A578EC20-D731-4211-B8F2-AF10739BE4E2Q36031075-D05AC7D0-1681-46BA-A784-C5DD96C6D3ADQ36072561-145C4A62-79F2-4E82-8CAA-DBAE0252CDC4Q36599937-CDAD45C9-7521-4E75-BEC8-744CF1B1E2DCQ36605392-BF7DCA43-B5D3-4735-AD96-D61643735DC4Q36905575-15721DBA-2533-49FA-AD54-B68F6C1FCBA4Q40842821-155953C4-73A7-43FB-A19C-C46CEA7F1A05Q40976937-42A2EBF2-2600-410F-82ED-6CC50D34E07CQ41155867-9FBB250B-2658-4AA3-A351-5BED572D6EBCQ42536187-4B20031A-06D3-4E28-9857-AEF9B392050BQ42540806-B9A6CC0D-DFA2-4E8B-87F6-6F3EF4CF5C25Q42548735-A8B397FC-16D2-4A08-AA1E-8C7D3AC12B69Q43637289-59C36E04-813B-47CD-81CF-BF5DBCA08B50Q44032657-3A0F716D-76DE-4336-B040-1B023B9C8C4EQ44179752-8C7062A0-1844-4E4A-830F-7001FF8110FAQ44844971-462DB464-DE29-488A-AD7C-F1764836BDDCQ46718056-A47E9101-6CF6-4C01-A3A6-5E48F431821BQ47653740-3A4C5248-D935-4E7A-8087-1E1D9A6563BBQ48566470-6945E570-8A9B-4F98-900E-C146DA6D61A7Q51910625-84C604F8-44F3-4553-8C51-F238F8F49D25Q52147205-C74CF98D-A5CB-47D1-85ED-990A1B807EC1Q52932431-AC3B3536-46EB-4BAF-9918-CE85E6780BAB
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Recent advances: the cytochrome P450 enzymes.
@en
type
label
Recent advances: the cytochrome P450 enzymes.
@en
prefLabel
Recent advances: the cytochrome P450 enzymes.
@en
P1476
Recent advances: the cytochrome P450 enzymes.
@en
P2093
D J Edwards
R L Slaughter
P304
P356
10.1177/106002809502900612
P407
P577
1995-06-01T00:00:00Z